We are live on ! Find out more
PRC

Pearl River Capital Portfolio holdings

AUM $630M
1-Year Est. Return 17.08%
This Fund
S&P 500
This Quarter Est. Return
-20.09%
1 Year Est. Return
+17.08%
3 Year Est. Return
+20.29%
5 Year Est. Return
+57.93%
10 Year Est. Return
–
AUM
$21.6M
AUM Growth
–
Cap. Flow
+$24.6M
Cap. Flow %
113.69%
Top 10 Hldgs %
5.91%
Holding
811
New
811
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$181K
2
SLB icon
SLB Ltd
SLB
+$174K
3
HES
Hess
HES
+$165K
4
PM icon
Philip Morris
PM
+$159K
5
EOG icon
EOG Resources
EOG
+$154K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 15.48%
2 Technology 12.98%
3 Industrials 12.68%
4 Healthcare 11.79%
5 Real Estate 11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DCPH
776
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$3K 0.01%
+131
New +$3.22K
COHR
777
DELISTED
Coherent Inc
COHR
$3K 0.01%
+32
New +$4.11K
XENT
778
DELISTED
Intersect ENT, Inc
XENT
$3K 0.01%
+100
New +$2.93K
CTB
779
DELISTED
Cooper Tire & Rubber Co.
CTB
$3K 0.01%
+100
New +$3.04K
CHK
780
DELISTED
Chesapeake Energy Corporation
CHK
$3K 0.01%
+8
New +$5.51K
PEI
781
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$3K 0.01%
+33
New +$4.11K
VG
782
DELISTED
Vonage Holdings Corporation
VG
$3K 0.01%
+291
New +$3.33K
TCF
783
DELISTED
TCF Financial Corporation
TCF
$3K 0.01%
+154
New +$3.33K
BCC icon
784
Boise Cascade
BCC
$2.73B
$2K 0.01%
+100
New +$2.87K
CCS icon
785
Century Communities
CCS
$1.98B
$2K 0.01%
+100
New +$2.08K
NKTR icon
786
Nektar Therapeutics
NKTR
$2.39B
$2K 0.01%
+3
New +$1.81K
NYT icon
787
New York Times
NYT
$12.6B
$2K 0.01%
+100
New +$2.53K
PBYI icon
788
Puma Biotechnology
PBYI
$398M
$2K 0.01%
+100
New +$3K
RITM icon
789
Rithm Capital
RITM
$5.58B
$2K 0.01%
+134
New +$2.26K
SANM icon
790
Sanmina
SANM
$8.78B
$2K 0.01%
+100
New +$2.52K
VYX icon
791
NCR Voyix
VYX
$1.19B
$2K 0.01%
+165
New +$2.59K
WWW icon
792
Wolverine World Wide
WWW
$1.68B
$2K 0.01%
+76
New +$2.59K
RVNC
793
DELISTED
Revance Therapeutics, Inc.
RVNC
$2K 0.01%
+100
New +$2.2K
EXPR
794
DELISTED
Express, Inc.
EXPR
$2K 0.01%
+15
New +$2.32K
CMD
795
DELISTED
Cantel Medical Corporation
CMD
$2K 0.01%
+23
New +$1.9K
CHSP
796
DELISTED
Chesapeake Lodging Trust
CHSP
$2K 0.01%
+100
New +$2.88K
DCH
797
Dauch Corp
DCH
$1.31B
$1K ﹤0.01%
+100
New +$1.34K
BRY
798
DELISTED
Berry Corp
BRY
$1K ﹤0.01%
+100
New +$1.34K
CI icon
799
Cigna
CI
$78.4B
$1K ﹤0.01%
+6
New +$1.25K
HBAN icon
800
Huntington Bancshares
HBAN
$34B
$1K ﹤0.01%
+100
New +$1.39K
29 30 31
32
33

Similar funds

SCM
Sahana Capital Management Greenwich, Connecticut $645M AUM 23.48% 1-Year Est. Return
IFAM
Institutional & Family Asset Management Fort Collins, Colorado $654M AUM 12.29% 1-Year Est. Return
GIM
Greylin Investment Management Orange, Virginia $598M AUM 18.59% 1-Year Est. Return
MCM
McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return
AT
Arden Trust Wilmington, Delaware $716M AUM 17.63% 1-Year Est. Return
AC
Abbrea Capital Greenbrae, California $755M AUM 24.68% 1-Year Est. Return
PWS
Private Wealth Strategies New Albany, Ohio $498M AUM 17.23% 1-Year Est. Return
RVPG
Relative Value Partners Group $772M AUM 15.6% 1-Year Est. Return

Pearl River Capital's Q4 2018 Portfolio in Review

Q4 2018 is the first quarter with a 13F filing on record for Pearl River Capital, which disclosed 811 positions worth $21.6M. Its ten largest holdings account for 5.9% of the portfolio.

Its largest position is NVIDIA: 37,760 shares worth $126K.

By sector, the portfolio is most concentrated in Financials at 15% of assets, followed by Technology and Industrials.

  • Pearl River Capital's largest Q4 2018 buy was NVIDIA: 37,760 shares worth $126K.
  • Pearl River Capital's ten largest holdings make up 5.9% of its $21.6M portfolio in Q4 2018.
  • Pearl River Capital disclosed 811 positions in Q4 2018, its first 13F filing on record.

Based on Pearl River Capital's 13F filing for Q4 2018, filed 8 Feb 2019.